Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) in a two-year-old

Hal Steven Farkas1, Ellen Werber Leschek2

  • 1College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA.

Open Journal of Clinical & Medical Case Reports
|July 12, 2024
PubMed

Insights

Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS) can occur in young children. Early testing and treatment for streptococcal pharyngitis in children under 3 are crucial to prevent serious complications.

Area of Science:

  • Pediatric infectious diseases
  • Pediatric neurology
  • Immunology

Background:

  • Current guidelines often do not recommend routine testing for streptococcal pharyngitis in children under 3.
  • This approach is based on the perceived low incidence and risk of complications in this age group.

Purpose of the Study:

  • To highlight the potential for serious complications, including PANDAS, from streptococcal pharyngitis in children under 3.
  • To advocate for increased consideration of testing and treatment in this demographic.

Main Methods:

  • Case report presentation of a 2-year-old diagnosed with PANDAS secondary to streptococcal pharyngitis.
  • Review of existing literature and guidelines regarding streptococcal pharyngitis in young children.

Main Results:

  • The case demonstrates that streptococcal pharyngitis and its complications, such as PANDAS, can occur in children under 3.
  • Such infections, though potentially underestimated, can lead to significant short- and long-term health issues.

Conclusions:

  • Testing and treatment for streptococcal pharyngitis should be strongly considered in children under 3 with clinical signs of infection or suspected immune-mediated complications.
  • Early intervention may prevent or mitigate the severity of both acute and chronic sequelae of streptococcal infections in this vulnerable population.

Related Concept Videos